Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

HRMY

Harmony Biosciences Holdings Inc

Jan 24 • 04:00PM ET

38.01

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Peers: MRK LLY PFE JNJ AMGN VRTX REGN GILD BIIB NBIX

| Held by: IJR CALF VTI IWM VB AVUV VBK VXF IJT SPSM

Scroll to Statements

Index	RUT	P/E	17.99	EPS (ttm)	2.11	Insider Own	29.00%	Shs Outstand	57.03M	Perf Week	-1.38%
Market Cap	2.17B	Forward P/E	11.39	EPS next Y	3.34	Insider Trans	-36.12%	Shs Float	40.49M	Perf Month	10.88%
Income	122.62M	PEG	0.60	EPS next Q	0.72	Inst Own	66.77%	Short Float	14.09%	Perf Quarter	9.04%
Sales	681.88M	P/S	3.18	EPS this Y	10.31%	Inst Trans	-10.73%	Short Ratio	7.39	Perf Half Y	15.81%
Book/sh	10.46	P/B	3.63	EPS next Y	42.07%	ROA	14.38%	Short Interest	5.71M	Perf Year	19.79%
Cash/sh	7.20	P/C	5.28	EPS next 5Y	29.97%	ROE	22.75%	52W Range	28.14 - 41.61	Perf YTD	10.46%
Dividend Est.	-	P/FCF	9.85	EPS past 5Y	-	ROI	16.02%	52W High	-8.65%	Beta	0.80
Dividend TTM	-	Quick Ratio	3.20	Sales past 5Y	683.02%	Gross Margin	75.16%	52W Low	35.07%	ATR (14)	1.53
Dividend Ex-Date	-	Current Ratio	3.24	EPS Y/Y TTM	-14.96%	Oper. Margin	25.71%	RSI (14)	59.66	Volatility	4.27% 3.93%
Employees	246	Debt/Eq	0.38	Sales Y/Y TTM	25.83%	Profit Margin	17.98%	Recom	1.38	Target Price	54.25
Option/Short	Yes / Yes	LT Debt/Eq	0.28	EPS Q/Q	25.17%	Payout	0.00%	Rel Volume	0.84	Prev Close	38.01
Sales Surprise	1.07%	EPS Surprise	18.81%	Sales Q/Q	16.08%	Earnings	Oct 29 BMO	Avg Volume	772.30K	Price	38.01
SMA20	5.34%	SMA50	9.47%	SMA200	13.42%	Trades		Volume	650,101	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-17-24	Initiated	H.C. Wainwright	Buy	$75
Oct-10-24	Resumed	Raymond James	Outperform
Sep-10-24	Initiated	UBS	Buy	$56
Jun-21-24	Initiated	Citigroup	Buy	$48
Jan-02-24	Downgrade	BofA Securities	Neutral → Underperform	$30
Sep-25-23	Downgrade	Goldman	Neutral → Sell	$40 → $31
Sep-07-23	Initiated	Berenberg	Buy	$59
Apr-20-23	Initiated	BofA Securities	Neutral	$35
Oct-14-22	Upgrade	Jefferies	Hold → Buy	$57 → $61
Oct-14-22	Upgrade	Janney	Neutral → Buy	$57 → $61
Aug-03-22	Downgrade	Jefferies	Buy → Hold	$57
Jul-13-22	Downgrade	Goldman	Buy → Neutral	$55
Jul-07-22	Initiated	Mizuho	Buy	$64
Apr-14-22	Initiated	Cantor Fitzgerald	Overweight	$63
Dec-01-21	Initiated	Oppenheimer	Outperform	$55
Nov-04-21	Initiated	Raymond James	Outperform	$58
Sep-23-21	Initiated	Needham	Buy	$57
Mar-29-21	Upgrade	Goldman	Neutral → Buy	$41 → $43
Sep-14-20	Initiated	Piper Sandler	Overweight	$61
Sep-14-20	Initiated	Jefferies	Buy	$51

Show Previous Ratings

Jan-20-25 09:40AM	Should Value Investors Buy Harmony Biosciences (HRMY) Stock? (Zacks)
Jan-15-25 12:20PM	Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge (Zacks)
09:55AM	How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48% (Zacks)
08:11AM	Harmony Biosciences price target raised to $32 from $31 at BofA (TipRanks)
Jan-13-25 04:15PM	Why Harmony Biosciences (HRMY) Is the Top Small Cap Stock to Buy with the Highest Upside Potential (Insider Monkey) +7.65%
04:15PM	Loading…
04:15PM	BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps. (Investor's Business Daily)
08:05AM	Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts (Business Wire)
Dec-18-24 08:05AM	HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Dec-03-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT (PR Newswire)
Nov-21-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES (PR Newswire)
Nov-01-24 09:40AM	Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? (Zacks)
Oct-30-24 10:30PM	Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders (PR Newswire) -18.53%
06:00AM	Axonis Therapeutics Announces $115 Million Series A Financing (PR Newswire)
03:06AM	Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
02:26AM	Q3 2024 Harmony Biosciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
05:15PM	Loading…
Oct-29-24 05:15PM	Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders (PR Newswire) +16.06%
04:12PM	Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat (Investor's Business Daily)
04:00PM	Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript (Motley Fool)
08:40AM	Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates (Zacks)
07:30AM	HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS (PR Newswire)
Oct-22-24 10:01AM	Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-16-24 08:05AM	HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024 (PR Newswire)
Oct-14-24 09:51AM	Wall Street Analysts Favor Harmony Biosciences Holdings, Inc. (HRMY) for Growth (Insider Monkey)
Oct-11-24 12:14PM	Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving Technical Ratings According To Piper Sandler? (Insider Monkey)
Oct-09-24 05:02PM	Harmony Biosciences Holdings Inc (HRMY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
Oct-03-24 11:11AM	Mizuho adds 2 new stocks to its Top Picks list (Investing.com)
Oct-01-24 08:45AM	HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY (PR Newswire)
Sep-29-24 04:43AM	Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts? (Insider Monkey)
Sep-27-24 05:23AM	Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains? (Zacks)
Sep-26-24 08:05AM	HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024 (PR Newswire) +6.70%
09:40AM	Loading…
Sep-25-24 09:40AM	Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? (Zacks)
Sep-24-24 12:00PM	Harmony Biosciences (HRMY) Upgraded to Buy: Here's What You Should Know (Zacks)
Sep-21-24 02:26AM	Harmony Biosciences Holdings, Inc. (HRMY): Short Seller Sentiment is Bearish (Insider Monkey)
Sep-10-24 02:56PM	Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says (Benzinga)
Aug-26-24 09:40AM	Is Harmony Biosciences (HRMY) a Great Value Stock Right Now? (Zacks)
Aug-21-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES (PR Newswire)
Aug-16-24 12:20PM	Surging Earnings Estimates Signal Upside for Harmony Biosciences (HRMY) Stock (Zacks)
Aug-14-24 09:55AM	Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect? (Zacks)
Aug-09-24 09:40AM	Should Value Investors Buy Harmony Biosciences (HRMY) Stock? (Zacks)
Aug-06-24 09:15PM	Harmony Biosciences (HRMY) Q2 2024 Earnings Call Transcript (Motley Fool) +6.18%
08:45AM	Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:30AM	Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028 (GlobeNewswire)
Jul-23-24 08:05AM	HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024 (PR Newswire)
Jul-19-24 09:55AM	Wall Street Analysts See a 32.82% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High? (Zacks)
Jul-17-24 09:50AM	Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? (Zacks)
Jul-09-24 06:00AM	7 Cheap Biotech Stocks With Major Upside Potential (InvestorPlace) +6.24%
Jul-01-24 02:18PM	7 Undervalued Biotech Stocks to Buy for Big-Time Returns (InvestorPlace)
Jun-25-24 08:05AM	HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT) (PR Newswire)
08:05AM	HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX (PITOLISANT) (PR Newswire)
Jun-24-24 12:56PM	7 Biotech Stocks to Buy on the Dip: June 2024 (InvestorPlace)
07:00AM	HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION APPROVAL FOR WAKIX (PITOLISANT) IN PEDIATRIC PATIENTS WITH NARCOLEPSY (PR Newswire)
Jun-05-24 08:05AM	HARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1 (PR Newswire)
May-28-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
May-01-24 12:45PM	Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice (Zacks)
11:07AM	Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-30-24 05:45PM	Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript (Motley Fool) +5.68%
01:44PM	Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View (Benzinga)
11:54AM	HRMY Stock Earnings: Harmony Biosciences Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
10:54AM	Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise (MT Newswires)
09:12AM	Harmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024 (GuruFocus.com)
07:05AM	Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy (GlobeNewswire)
07:00AM	Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets (PR Newswire)
Apr-16-24 08:05AM	HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 (PR Newswire)
Apr-11-24 08:05AM	HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST (PR Newswire) +6.44%
Apr-03-24 08:05AM	HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME (PR Newswire)
Mar-26-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE (PR Newswire)
Mar-19-24 01:26AM	Harmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Shares (GuruFocus.com)
Mar-08-24 09:38AM	10 Biotech Stocks with Huge Potential (Insider Monkey)
Feb-28-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES (PR Newswire)
Feb-23-24 11:58AM	Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-22-24 11:57PM	Q4 2023 Harmony Biosciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:30PM	Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript (Motley Fool)
08:45AM	Harmony Biosciences Holdings, Inc. (HRMY) Misses Q4 Earnings and Revenue Estimates (Zacks)
08:12AM	Harmony Biosciences Holdings Inc (HRMY) Reports Robust Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
07:30AM	Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates (GlobeNewswire)
Feb-21-24 08:05AM	U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX (PITOLISANT) IN PEDIATRIC NARCOLEPSY (PR Newswire)
Feb-20-24 08:05AM	HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME (PR Newswire)
Feb-12-24 09:28AM	The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024 (InvestorPlace)
Feb-08-24 08:05AM	HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024 (PR Newswire) +5.68%
Feb-07-24 12:36PM	The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024 (InvestorPlace)
Jan-23-24 09:55AM	Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade (Zacks)
04:16AM	18 High Growth Low PE Stocks (Insider Monkey)
Jan-12-24 09:55AM	Bears are Losing Control Over Harmony Biosciences Holdings, Inc. (HRMY), Here's Why It's a 'Buy' Now (Zacks)
Jan-08-24 08:05AM	HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCE (PR Newswire)
Jan-05-24 09:55AM	Does Harmony Biosciences Holdings, Inc. (HRMY) Have the Potential to Rally 32.19% as Wall Street Analysts Expect? (Zacks)
Jan-04-24 12:00PM	All You Need to Know About Harmony Biosciences Holdings, Inc. (HRMY) Rating Upgrade to Buy (Zacks)
Jan-03-24 08:05AM	HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Jan-02-24 06:38PM	Why Harmony Biosciences Stock Got Slammed Today (Motley Fool)
Dec-17-23 12:03PM	7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar (InvestorPlace)
Dec-07-23 08:53PM	Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On (InvestorPlace)
08:05AM	HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1 (PR Newswire)
Dec-05-23 01:02PM	16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds (Insider Monkey)
08:05AM	HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING (PR Newswire)
Nov-29-23 09:55AM	Wall Street Analysts Predict a 44.38% Upside in Harmony Biosciences Holdings, Inc. (HRMY): Here's What You Should Know (Zacks)
Nov-16-23 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCE (PR Newswire)
Nov-15-23 08:05AM	HARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING COMPANIES IN NORTH AMERICA ON THE 2023 DELOITTE TECHNOLOGY FAST 500 (PR Newswire)
Nov-13-23 09:55AM	How Much Upside is Left in Harmony Biosciences Holdings, Inc. (HRMY)? Wall Street Analysts Think 76.62% (Zacks)
Nov-08-23 09:40AM	Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? (Zacks)
08:05AM	HARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD OF DIRECTORS (PR Newswire)
Nov-06-23 09:50AM	Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2023 Earnings Call Transcript (Insider Monkey)

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JEFFREY G DIERKS	Officer	Jan 24 '25	Proposed Sale	38.01	13,125	498,881		Jan 24 04:18 PM
Dayno Jeffrey M.	PRESIDENT, CEO	Jan 21 '25	Option Exercise	8.22	19,293	158,588	19,293	Jan 23 04:17 PM
Dayno Jeffrey M.	PRESIDENT, CEO	Jan 21 '25	Sale	40.13	19,293	774,245	0	Jan 23 04:17 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Jan 21 '25	Option Exercise	29.03	25,000	725,750	25,000	Jan 23 04:15 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Jan 21 '25	Sale	40.18	25,000	1,004,598	0	Jan 23 04:15 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 16 '25	Option Exercise	33.44	29,475	985,644	29,475	Jan 21 08:44 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 21 '25	Option Exercise	33.44	1,123	37,553	1,123	Jan 21 08:44 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 16 '25	Sale	37.41	29,475	1,102,795	0	Jan 21 08:44 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 21 '25	Sale	40.00	1,123	44,920	0	Jan 21 08:44 PM
SANDIP KAPADIA	Officer	Jan 21 '25	Proposed Sale	39.05	25,000	976,250		Jan 21 04:21 PM
JEFFREY M DAYNO	Director	Jan 21 '25	Proposed Sale	39.05	19,293	753,392		Jan 21 04:21 PM
JEFFREY G DIERKS	Officer	Jan 21 '25	Proposed Sale	39.05	1,123	43,853		Jan 21 04:20 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 15 '25	Option Exercise	33.44	10,507	351,354	10,507	Jan 16 04:30 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 15 '25	Sale	37.01	10,507	388,841	0	Jan 16 04:30 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 13 '25	Option Exercise	33.44	7,180	240,099	7,180	Jan 15 04:30 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 13 '25	Sale	37.04	7,180	265,946	0	Jan 15 04:30 PM
JEFFREY G DIERKS	Officer	Jan 13 '25	Proposed Sale	33.86	47,162	1,596,905		Jan 13 04:26 PM
Valor IV Pharma Holdings, LLC	10% Owner	Nov 01 '24	Sale	30.30	4,000,000	121,210,000	7,218,033	Nov 05 05:48 PM
Valor IV Pharma Holdings, LLC	10% Owner	Nov 05 '24	Sale	30.30	600,000	18,181,500	6,618,033	Nov 05 05:48 PM
Marshman Fund Trust II	10% Owner	Nov 01 '24	Sale	30.30	4,000,000	121,210,000	6,651,120	Nov 05 04:05 PM
Marshman Fund Trust II	10% Owner	Nov 05 '24	Sale	30.30	600,000	18,181,500	6,051,120	Nov 05 04:05 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Oct 29 '24	Option Exercise	24.00	21,496	515,904	21,496	Oct 31 04:45 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Oct 29 '24	Sale	40.47	21,496	870,018	0	Oct 31 04:45 PM
JEFFREY G DIERKS	Officer	Oct 29 '24	Proposed Sale	35.75	21,496	768,482		Oct 29 04:22 PM
JEFFREY G DIERKS	Officer	Oct 03 '24	Proposed Sale	35.57	14,961	532,163		Oct 03 04:32 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Oct 01 '24	Option Exercise	24.00	400	9,600	400	Oct 02 04:06 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Oct 01 '24	Sale	40.19	400	16,077	0	Oct 02 04:06 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 30 '24	Option Exercise	0.00	60,000	0	60,000	Oct 02 04:05 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Sep 30 '24	Option Exercise	0.00	60,000	0	60,000	Oct 02 04:04 PM
JEFFREY G DIERKS	Officer	Oct 01 '24	Proposed Sale	40.00	21,796	871,840		Oct 01 04:35 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 30 '24	Option Exercise	24.00	35,846	860,304	35,846	Oct 01 04:07 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 30 '24	Sale	40.03	35,846	1,434,951	0	Oct 01 04:07 PM
JEFFREY G DIERKS	Officer	Sep 30 '24	Proposed Sale	39.13	7,175	280,758		Sep 30 04:28 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 27 '24	Option Exercise	24.00	200	4,800	200	Sep 30 04:03 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 27 '24	Sale	40.05	200	8,009	0	Sep 30 04:03 PM
JEFFREY G DIERKS	Officer	Sep 27 '24	Proposed Sale	39.79	28,971	1,152,756		Sep 27 04:24 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Mar 29 '24	Option Exercise	0.00	15,000	0	15,000	Apr 02 04:31 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 15 '24	Option Exercise	8.22	11,979	98,467	11,979	Mar 18 07:24 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 15 '24	Sale	32.00	11,979	383,328	0	Mar 18 07:24 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 08 '24	Option Exercise	8.22	194	1,595	194	Mar 11 05:17 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 08 '24	Sale	32.00	194	6,208	0	Mar 11 05:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HRMY

Harmony Biosciences Holdings Inc

Upgrade your FINVIZ experience